Thoracoscopic pericardial window surgery for complex postoperative pericardial effusion after cardiac surgery: A case series

Nguyen Duy Gia, Nguyen Quang Huy, Nguyen Duy Thang, Le Van Hung, Trinh Thi Thanh Tuyen, Trieu The Anh, Vu Ngoc Tu

Nội dung chính của bài viết

Tóm tắt

Postoperative pericardial effusion is a common complication after cardiac surgery, particularly when the effusion is recurrent, or clinically significant. When the effusion is predominantly posterior, or associated with clot formation, percutaneous drainage begins difficult or ineffective. We retrospectively reviewed 6 patients who developed clinically significant pericardial effusion after open cardiac surgery and underwent left thoracoscopic posterior pericardial window. Imaging showed non-drainable loculated or posterior effusions in all cases. The interval from surgery to effusion ranged from 10 days to 2 months. Intraoperative findings included clotted hemopericardium, hemorrhagic effusion, and serous effusion. Histopathology showed chronic pericarditis without malignancy or tuberculosis. All patients improved after surgery, with no recurrence, mortality, or major complication at 3 months.

Chi tiết bài viết

Tài liệu tham khảo

1. Ashikhmina EA, Schaff HV, Sinak LJ, et al. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management. Ann Thorac Surg. 2010;89(1):112-118. doi:10.1016/j.athoracsur.2009.09.026
2. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015; 36(42): 2921-2964. doi:10.1093/eurheartj/ehv318.
3. Imazio M, Trinchero R, Brucato A, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010; 31(22): 2749-2754. doi:10.1093/eurheartj/ehq319.
4. Imazio M. The post-pericardiotomy syndrome. Curr Opin Pulm Med. 2012; 18(4): 366-374. doi:10.1097/MCP.0b013e32835311a2.
5. Jung HO. Pericardial Effusion and Pericardiocentesis: Role of Echocardiography. Korean Circ J. 2012; 42(11): 725-734. doi:10.4070/kcj.2012.42.11.725.
6. Liu HP, Chang CH, Lin PJ, Hsieh HC, Chang JP, Hsieh MJ. Thoracoscopic management of effusive pericardial disease: indications and technique. Ann Thorac Surg. 1994; 58(6): 1695-1697. doi:10.1016/0003-4975(94)91663-2.
7. Langdon SE, Seery K, Kulik A. Contemporary outcomes after pericardial window surgery: impact of operative technique. J Cardiothorac Surg. 2016; 11(1): 73. doi:10.1186/s13019-016-0466-3.
8. O’Brien PKH, Kucharczuk JC, Marshall MB, et al. Comparative study of subxiphoid versus video-thoracoscopic pericardial “window.” Ann Thorac Surg. 2005; 80(6): 2013-2019. doi:10.1016/j.athoracsur.2005.05.059.
9. Georghiou GP, Stamler A, Sharoni E, et al. Video-assisted thoracoscopic pericardial window for diagnosis and management of pericardial effusions. Ann Thorac Surg. 2005; 80(2): 607-610. doi:10.1016/j.athoracsur.2005.02.068.
10. Vakamudi S, Ho N, Cremer PC. Pericardial Effusions: Causes, Diagnosis, and Management. Prog Cardiovasc Dis. 2017; 59(4): 380-388. doi:10.1016/j.pcad.2016.12.009.
11. Imazio M, Brucato A, Rovere ME, et al. Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. Am J Cardiol. 2011; 108(8): 1183-1187. doi:10.1016/j.amjcard.2011.06.025.